Jash Engineering Limited (JASH.NS)
INR 609.2
(1.09%)
INR 609.2
(1.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 502.49 Million | 339.57 Million | 144.77 Million | 354.21 Million | 184.72 Million | 198.38 Million |
| Net Income | 667.69 Million | 564.93 Million | 345.79 Million | 361.68 Million | 277.43 Million | 146.23 Million |
| Depreciation & Amortization | 107.68 Million | 106.46 Million | 96.91 Million | 85.53 Million | 78.22 Million | 68.98 Million |
| Deferred income taxes | - | -164.96 Million | -107.56 Million | -103.16 Million | -52.47 Million | - |
| Stock-based compensation | 6.64 Million | 4.44 Million | 7.44 Million | 9.63 Million | 1.82 Million | - |
| Change in working capital | -224.83 Million | -256.78 Million | -260.14 Million | -87.44 Million | -212.7 Million | -61.24 Million |
| Other non-cash items | 429.57 Million | 85.46 Million | 62.32 Million | 87.96 Million | 92.42 Million | 44.4 Million |
| Investing Cash Flow | -706.06 Million | -158.46 Million | -163.72 Million | -121.06 Million | -81.89 Million | -173.56 Million |
| Investments in PPE | -243.6 Million | -161.18 Million | -129.5 Million | -94.67 Million | -42.68 Million | -161.59 Million |
| Acquisitions | 965 Thousand | 6.35 Million | - | 451 Thousand | 84 Thousand | 40 Thousand |
| Investment purchases | -463.42 Million | -16.03 Million | -49.18 Million | -37.9 Million | -43.91 Million | -15.78 Million |
| Sales/Maturities of investments | - | -6.35 Million | - | -451 Thousand | -84 Thousand | -40 Thousand |
| Other Investing Activities | -439.18 Million | 18.76 Million | 14.96 Million | 11.51 Million | 4.69 Million | 3.8 Million |
| Financing Cash Flow | 423.19 Million | -132.8 Million | 17.06 Million | -224.8 Million | -91.89 Million | -35.41 Million |
| Debt repayment | -39.11 Million | -42.16 Million | -57.01 Million | -220.7 Million | -133.47 Million | -111.77 Million |
| Dividends payments | -72.18 Million | -42.98 Million | -37.99 Million | -10.65 Million | -42.81 Million | -14.24 Million |
| Common Stock Repurchased | - | -58.16 Million | 44.58 Million | - | - | - |
| Common Stock Issuance | 523.4 Million | 10.51 Million | 12.42 Million | - | - | - |
| Other Financing Activities | 17.32 Million | -1000.00 | 55.05 Million | 6.55 Million | 84.39 Million | 90.6 Million |
| Accounts receivables | 57.04 Million | -63.51 Million | -347.83 Million | -117.98 Million | -85.99 Million | -205.49 Million |
| Accounts payables | 169.94 Million | -44.41 Million | 131.86 Million | 71.99 Million | -231.1 Million | 106.57 Million |
| Inventory | -489.23 Million | -339.69 Million | -44.44 Million | -106.48 Million | 8.99 Million | -109.47 Million |
| Other working capital | 37.41 Million | 190.84 Million | 262 Thousand | 65.01 Million | 95.4 Million | 147.15 Million |
| Cash at beginning of period | 88.74 Million | 37.62 Million | 38.59 Million | 30.93 Million | 18.1 Million | 28.7 Million |
| Cash at end of period | 955.73 Million | 88.74 Million | 37.62 Million | 38.59 Million | 30.93 Million | 18.1 Million |
| Capital Expenditure | -243.6 Million | -161.18 Million | -129.5 Million | -94.67 Million | -42.68 Million | -161.59 Million |
| Effect of forex changes on cash | 2.04 Million | 2.8 Million | 925 Thousand | -675 Thousand | 1.89 Million | 1.45 Million |
| Net cash flow / Change in cash | 866.99 Million | 51.11 Million | -966 Thousand | 7.66 Million | 12.83 Million | -10.6 Million |
| Free Cash Flow | 258.89 Million | 178.38 Million | 15.27 Million | 259.53 Million | 142.04 Million | 36.78 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.96 Million | 667.69 Million | 389.54 Million | 226.41 Million | 85.42 Million | -33.69 Million |
| Depreciation & Amortization | - | 107.68 Million | - | 25.99 Million | 26.61 Million | 27.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 6.64 Million | - | - | - | - |
| Change in working capital | - | -224.83 Million | - | - | - | - |
| Other non-cash items | -4.96 Million | 429.57 Million | -389.54 Million | -226.41 Million | -85.42 Million | 33.69 Million |
| Investing Cash Flow | - | -706.06 Million | - | - | - | - |
| Investments in PPE | - | -243.6 Million | - | - | - | - |
| Acquisitions | - | 965 Thousand | - | - | - | - |
| Investment purchases | - | -463.42 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -439.18 Million | - | - | - | - |
| Financing Cash Flow | - | 423.19 Million | - | - | - | - |
| Debt repayment | - | -39.11 Million | - | - | - | - |
| Dividends payments | - | -72.18 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 523.4 Million | - | - | - | - |
| Other Financing Activities | - | 17.32 Million | - | - | - | - |
| Accounts receivables | - | 57.04 Million | - | - | - | - |
| Accounts payables | - | 169.94 Million | - | - | - | - |
| Inventory | - | -489.23 Million | - | - | - | - |
| Other working capital | - | 37.41 Million | - | - | - | - |
| Cash at beginning of period | - | 88.74 Million | - | 421.79 Million | 368.55 Million | 88.74 Million |
| Cash at end of period | - | 955.73 Million | - | 473.77 Million | 421.79 Million | 143.2 Million |
| Capital Expenditure | - | -243.6 Million | - | - | - | - |
| Effect of forex changes on cash | - | 2.04 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 866.99 Million | - | 51.98 Million | 53.23 Million | 54.46 Million |
| Free Cash Flow | - | 258.89 Million | - | 51.98 Million | 53.23 Million | 54.46 Million |
4320
PRIMESECU
AUROPHARMA
8037
060280
VEOEY